Paper Presented

2015

1

Abdelwahid Saeed Ali, Ahmed Musa Alhakami, Ali Mohd Alsuheel, Ayed Alshati and O. M. S.Abdul-Wahab. Clinical and laboratory investigations of Human metapneumovirus (hMPV) in infants and young children with pneumonia and bronchiolitis in Saudi Arabia. Presented as abstract  at World Congress on Infectious Diseases, August 10-12, 2015 London, UK. Published in J. Infect. Dis. Ther 2015, 3:4.

2014

2

Hamali HA, Goodall AH. Differences between platelet activation and apoptosis: the role of ROS production in the procoagulant response. The 7th symposium on Haemostasis, University of North Carolina, Chapel Hill, North Carolina, USA. 15-17 May 2014. 

3

Hamali HA, Altayar O, Jamil A, Alshehri A. Level of procoagulant microvesicles in steady-state sickle cell anaemia patients. ISEV 2014 meeting, Rotterdam, the Netherlands.29th April- 3rd May 2014.

2013

4

Abdul-Wahab, O.M.S., A. M. Al-Hakami, A. A.Shati, A. M. Alsuheel, A. Kumar and F. Benahme. Presented a Poster titled (2013) “Association of Mycoplasma pneumonia with Respiratory Tract Infections in Children”at the European Mycoplasma Meeting: “Mycoplasmas – a practical approach“ that held from 6th to 8th June 2013 in Dubrovnik, Croatia

2012

5

Alsahli MA, Hamali HA, Goodall AH.Characterisation of the procoagulant properties of microparticles derived from different cell types. BSHT annual meeting and UK platelet meeting, Bath, UK. October 2012.

6

Alsahli MA, Appleby JA,Hamali HA, Wright JR,Watson SP, Goodall AH. Signalling via CLEC-2 generates a procoagulant response in platelets.BSHT annual meeting and UK platelet meeting, Bath, UK. October 2012.

2011

7

Vogler M, Hamali HA, Bampton ETW, Dinsdale D, Dyer MJS, Goodall AH, Cohen GM.Platelet Toxicity Induced By the BCL2-Inhibitor ABT-263, A Novel Anti-Cancer Agent.Published in Toxicology290(2-3):108. December 2011.

8

Hamali HA, Vogler M, Cohen GM, Goodall AH. Differences between platelet activation and apoptosis: the role of ROS production in the procoagulant response. BSHT annual meeting, Brighton, UK. October 2011. 

9

Hamali HA, Vogler M, Cohen GM, Goodall AH.Differences between platelet activation and apoptosis: the role of ROS production in the procoagulant response. Presented as a poster at the Saudi international Conference V, Warwick University, Warwick, UK. June 2011.

2010

10

Burton JO, Hamali HA, Stansfield R, Patel A, Goodall AH, and Brunskill NJ. Elevated Levels of Plasma Microparticles in Dialysis Patients are Associated with a Pro-coagulant State. American Society of Nephrology, USA. October 2010.

11

Hamali HA,Goodall AH. Role of ROS production in the collagen-mediated procoagulant response in platelets.Presented as a talk at the Nottingham Platelet Conference, Nottingham, UK. July 2010. Published in 2010; 21(5):393-419.

12

Hamali HA, Goodall AH. Analyzing the effect of platelet-derived microparticles on the calibrated automated thrombography: assay and pre-analytical variables. Presented as a talk at the International Society for Laboratory Haematology, Brighton, UK. May 2010. Published in International Journal of Laboratory Hematology; 2010; 32(s1):1-176.

2009

13

Hamali HA, Appleby JA, O’Donnell VB, Goodall AH. The role of 12-lipoxygenase and NADPH in the generation of procoagulant phospholipids on platelets activated through GPVI.Presented as a talk at the First French-UK platelet meeting, Toulouse, France. October 2009.